Literature DB >> 27046094

High expression of Rab3D predicts poor prognosis and associates with tumor progression in colorectal cancer.

Yang Luo1, Guang-Yao Ye1, Shao-Lan Qin1, Yi-Fei Mu1, Lei Zhang1, Yang Qi1, Yi-Er Qiu1, Min-Hao Yu2, Ming Zhong3.   

Abstract

Rab3D belongs to Rab protein family. Previous reports showed that the expression of Rab3D was dysregulated in various types of cancer. Rab3D belongsRab3D belongs. However, little is known about the role of Rab3D in carcinogenesis and progression of colorectal cancer (CRC). Here, we first evaluated the expression of Rab3D in 32 fresh CRC and matched normal tissues and found Rab3D was dramatically increased in CRC tissues compared to normal tissues (p<0.001). Furthermore, immunochemistry was used to investigate Rab3D expression in 300CRC tissue specimens. The expression of Rab3D significantly positively correlated with the tumor size (p=0.041), CEA level (p=0.007), tumor classification (p=0.030), lymphatic metastasis (p<0.001), distant metastasis (p=0.013) and clinical stage (p=0.003). We also demonstrated that overall survival is poor in CRC patients with high expression of Rab3D (p<0.001). Finally, we showed that Rab3D activated Akt/GSK3β/Snail pathway and induced EMT process in colorectal cancer cells. In conclusion, this study establishes increased Rab3D expression is associated with invasiveness of CRC cells, and Rab3D expression status may serve as a reliable prognostic biomarker in CRC patients. Crown
Copyright © 2016. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; EMT; Prognosis; Rab3D; Snail

Mesh:

Substances:

Year:  2016        PMID: 27046094     DOI: 10.1016/j.biocel.2016.03.017

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  13 in total

Review 1.  Consequences of Rab GTPase dysfunction in genetic or acquired human diseases.

Authors:  Marcellus J Banworth; Guangpu Li
Journal:  Small GTPases       Date:  2017-12-28

2.  Hsa_circ_0103232 promotes melanoma cells proliferation and invasion via targeting miR-661/RAB3D.

Authors:  Xing Lin; Liang Zhong; Nian Wang; Xuan Chu; Beizhong Liu
Journal:  Cell Cycle       Date:  2022-05-13       Impact factor: 5.173

3.  Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT).

Authors:  Lin Zhang; Juan Ye; Qiuyun Luo; Miaohuan Kuang; Minjie Mao; Shuqin Dai; Xueping Wang
Journal:  Cancer Manag Res       Date:  2020-07-03       Impact factor: 3.989

4.  MiR-27b directly targets Rab3D to inhibit the malignant phenotype in colorectal cancer.

Authors:  Yang Luo; Shi-Yong Yu; Jian-Jun Chen; Jun Qin; Yi-Er Qiu; Ming Zhong; Min Chen
Journal:  Oncotarget       Date:  2017-12-12

5.  APE1/Ref-1 knockdown in pancreatic ductal adenocarcinoma - characterizing gene expression changes and identifying novel pathways using single-cell RNA sequencing.

Authors:  Fenil Shah; Emery Goossens; Nadia M Atallah; Michelle Grimard; Mark R Kelley; Melissa L Fishel
Journal:  Mol Oncol       Date:  2017-10-19       Impact factor: 6.603

6.  Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression.

Authors:  Takamichi Igarashi; Kenichiro Araki; Takehiko Yokobori; Bolag Altan; Takahiro Yamanaka; Norihiro Ishii; Mariko Tsukagoshi; Akira Watanabe; Norio Kubo; Tadashi Handa; Yasuo Hosouchi; Masahiko Nishiyama; Tetsunari Oyama; Ken Shirabe; Hiroyuki Kuwano
Journal:  Oncotarget       Date:  2017-02-14

7.  Long Noncoding RNA CAR10 Contributes to Melanoma Progression By Suppressing miR-125b-5p to Induce RAB3D Expression.

Authors:  Jing Xie; Yanyan Zheng; Xiaomin Xu; Congcong Sun; Mingfen Lv
Journal:  Onco Targets Ther       Date:  2020-06-29       Impact factor: 4.147

8.  The lncRNA HOXA11-AS regulates Rab3D expression by sponging miR-125a-5p promoting metastasis of osteosarcoma.

Authors:  Kun Cao; Yueyang Fang; Hao Wang; Zheng Jiang; Li Guo; Yong Hu
Journal:  Cancer Manag Res       Date:  2019-05-16       Impact factor: 3.989

9.  CircRNA hsa_circ_0087862 Acts as an Oncogene in Non-Small Cell Lung Cancer by Targeting miR-1253/RAB3D Axis.

Authors:  Lin Li; Ke Wan; Linkai Xiong; Shuang Liang; Fangfang Tou; Shanxian Guo
Journal:  Onco Targets Ther       Date:  2020-04-03       Impact factor: 4.147

10.  MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression.

Authors:  Wang Jiashi; Qiu Chuang; Zhang Zhenjun; Wang Guangbin; Li Bin; He Ming
Journal:  Aging (Albany NY)       Date:  2018-06-10       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.